NCT00288184View on ClinicalTrials.gov

Uric Acid in Essential Hypertension in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

March 31, 2007

Study Completion Date

August 31, 2007

Conditions
Essential Hypertension
Interventions
DRUG

Allopurinol

Allopurinol adminsitered one 200mg capsule by mouth twice daily. Placebo capsule once daily during crossover

DRUG

Placebo

Trial Locations (1)

77030

Texas Children's Hospital, Houston

All Listed Sponsors
collaborator

Baylor University

OTHER

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00288184 - Uric Acid in Essential Hypertension in Children | Biotech Hunter | Biotech Hunter